NEW YORK, Nov. 7 – Aclara BioSciences said Wednesday that Roche Applied Science had agreed to market its Arteas LabCard product, which is designed to allow researchers to run assays using small amounts of consumables.
Roche Applied Science, a business unit of Roche Diagnostics, will begin launching the Arteas product in the first quarter of next year. Until then, Aclara will continue selling its LabCards.
Roche has also obtained rights to negotiate to market additional Aclara products.
"After a thorough evaluation, we concluded that ACLARA possessed an unusual combination of strengths in both microfluidics and application chemistries, which together solve important customer needs,” Juergen Flach, general manager of Roche Diagnostics Corporation, said in a statement.
Aclara said that LabCard require 10 – 100 times less consumables than conventional microwell plates.